Intellia Therapeutics to Present at November Investor Healthcare Conferences
October 31 2016 - 6:00AM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome
editing company focused on the development of potentially curative
therapeutics using CRISPR/Cas9 technology, announced that senior
company leaders will present at key November investor healthcare
conferences, including the 25th Annual Credit Suisse Healthcare
Conference and the Jefferies 2016 London Healthcare Conference.
Details of the upcoming presentations are as follows:
Monday, November 7th 25th Annual Credit
Suisse Healthcare Conference, 2016Location: Scottsdale,
ArizonaPresentation Time: 11:30 AM MST
Thursday, November 17th Jefferies 2016
London Healthcare ConferenceLocation: London,
EnglandPresentation Time: 3:20 PM GMT
Individuals may access the presentations for each conference via
live webcast on the Intellia website at
www.intelliatx.com under "Events & Presentations" in the
"Investor Relations" section. A replay of the webcast will be
available on this site for 90 days following the live event.
About Intellia Therapeutics
Intellia Therapeutics is a leading genome editing company,
focused on the development of proprietary, potentially curative
therapeutics using the CRISPR/Cas9 system. Intellia believes the
CRISPR/Cas9 technology has the potential to transform medicine by
permanently editing disease-associated genes in the human body with
a single treatment course. Our combination of deep scientific,
technical and clinical development experience, along with our
leading intellectual property portfolio, puts us in a unique
position to unlock broad therapeutic applications of the
CRISPR/Cas9 technology and create a new class of therapeutic
products. Learn more about Intellia Therapeutics and CRISPR/Cas9 at
intelliatx.com; Follow us on Twitter @intelliatweets.
Media Contact:
Jennifer Mound Smoter
Chief External Affairs & Communications Officer
+1 857-706-1071
jenn.smoter@intelliatx.com
Investor Contacts:
John Graziano
Trout Group
+1 646-378-2942
jgraziano@troutgroup.com
Chad Rubin
Trout Group
+1 646-378-2947
crubin@troutgroup.com
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intellia Therapeutics (NASDAQ:NTLA)
Historical Stock Chart
From Jul 2023 to Jul 2024